Intelligent Gene Manufacturing for Gene Synthesis

The Growing Demand for Next-Generation Gene Synthesis

As the bioeconomy accelerates, artificial gene synthesis is becoming a foundational technology enabling innovation across biopharmaceuticals, life sciences research, agriculture, environmental applications, and biomanufacturing.

• More complex constructs: Applications such as gene circuits and multigene assemblies require longer DNA fragments and highly accurate assembly methods.
• Higher throughput demands: Antibody discovery, engineered microbes, and RNA therapeutics require a reliable supply of high-quality materials at scale.
• Larger production volumes: Material requirements increase rapidly as technologies advance from research applications to commercial manufacturing.
• Stricter quality standards: Gene therapy and pharmaceutical applications require full traceability and rigorous validation, including NGS-based quality testing.

Traditional, fragmented synthesis services are no longer sufficient to meet these challenges. The industry is moving toward integrated, end-to-end manufacturing capabilities that can deliver high-quality genetic materials at greater complexity, scale, and reliability.

Gene Factory: An Intelligent Manufacturing Platform

To meet the demands of next-generation biotechnology, Tsingke has developed the Gene Factory, an integrated manufacturing platform connecting the entire DNA production workflow.

Rather than focusing only on synthesis chemistry, the platform unifies sequence design, reagent production, molecular construction, quality control, and digital process management into a coordinated manufacturing ecosystem.

The Gene Factory is built on three core capabilities:

• Proprietary high-purity reagent manufacturing
• Advanced gene synthesis instrumentation developed in-house
• AI-driven automation and digital twin technology

Together, these capabilities improve synthesis efficiency, manufacturing scalability, production consistency, and quality control for increasingly complex genetic constructs.

Five Integrated Modules for End-to-End Gene Manufacturing

The Gene Factory establishes a closed-loop workflow covering design, synthesis, assembly, validation, and optimization.

1. AI-Powered Gene Design
The process begins with intelligent sequence optimization through the Tsingke HelixTech AI platform. Codon optimization, repeat reduction, sequence balancing, and manufacturability prediction improve design success before production begins.

2. High-Throughput DNA Synthesis
Proprietary synthesis technologies enable efficient production of complex DNA constructs, including long fragments, GC-rich sequences, repetitive regions, and multi-gene assemblies.

3. Automated DNA Assembly
Automated workflows support cloning, vector construction, and DNA assembly with reduced manual intervention, improving consistency and manufacturing throughput.

4. Comprehensive Sequence Validation
Quality control integrates Sanger sequencing and next-generation sequencing (NGS) technologies to confirm sequence accuracy and product integrity.

5. AI-Driven Manufacturing Optimization
Production and quality data continuously inform the AI system, enabling optimization of synthesis strategies, manufacturing parameters, and overall platform performance.

A Comprehensive DNA and RNA Manufacturing Portfolio

Building on the Gene Factory platform, Tsingke provides integrated solutions across DNA, RNA, and protein development.

Tsynth® Gene Synthesis

Tsynth® gene synthesis supports DNA constructs up to 200 kb, enabling the development of complex genetic circuits, metabolic pathways, and multi-gene vectors.

Capabilities include:

• Free codon optimization
• More than 200 cloning vector options
• Custom vector construction
• DNA template preparation for IVT
• Support for mRNA, saRNA, and circular RNA development
• LNP formulation services

Oligonucleotide Synthesis and Modification

Tsingke provides DNA and RNA oligonucleotide synthesis with more than 200 chemical modification options, including fluorescent labeling, phosphorylation, and phosphorothioate modifications.

Flexible purification options, including PAGE and HPLC, support applications ranging from molecular diagnostics to nucleic acid therapeutics such as siRNA and antisense oligonucleotides (ASOs).

Integrated Protein and Antibody Development

The platform extends beyond nucleic acid manufacturing through integrated services covering gene design, synthesis, vector construction, protein expression, and purification.
These capabilities accelerate antibody discovery, recombinant protein production, and protein engineering programs.

Built for Quality, Automation, and Reproducibility

Reliable gene manufacturing requires robust quality systems alongside advanced synthesis technologies.

The Gene Factory integrates standardized processes, automated production, comprehensive sequence verification, and digital traceability throughout the manufacturing workflow, enabling accurate, consistent, and reproducible delivery of biological materials.

Advance Your Biotechnology Project with Tsingke

Tsingke supports researchers, biotech companies, and industry partners throughout the development process, from early-stage design challenges to advanced production requirements. As the exclusive distributor in the Benelux, we make Tsingke’s gene synthesis and nucleic acid manufacturing solutions available locally.

For questions, please contact your Bio-Connect account manager or reach out via our contact page.